Valsartan
Treatment for Hypertension
Typical Dosage: 80-320mg daily
Effectiveness
86%
Safety Score
70%
Clinical Trials
258
Participants
350K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
80-320mg daily
Time to Effect
1-2 weeks
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
45(Treat 45 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30
Monitoring:$150
Side Effect Mgmt:$50
Total Annual:$230
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$10,000/QALY
QALYs Gained
0.5
Outcome-Based Costs
Cost per Responder
$383
Comparison vs No treatment
Cost Difference
$-230/year
Less expensive
QALY Difference
+0.50 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Valsartan Outcomes
for Hypertension
Efficacy Outcomes
Overall Effectiveness
+86%
Response Rate
+60%
Common Side Effects
Dizziness/Orthostatic Hypotension
+5%
Hyperkalemia
+3%
Renal impairment
+2%
Angioedema
+0.05%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
14 completed trials for Valsartan in Hypertension
To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
NCT01070043COMPLETEDPHASE4
60 participants
INTERVENTIONAL
Taipei, Taiwan
Started: Jun 1, 2009
A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan
NCT02343250COMPLETEDPHASE1
54 participants
INTERVENTIONAL
Started: Mar 1, 2015
A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension
NCT00457626COMPLETEDPHASE3
66 participants
INTERVENTIONAL
Hackensack, United States +35 more
Started: Apr 9, 2007
Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.
NCT01541189COMPLETEDPHASE4
200 participants
INTERVENTIONAL
Beijing, China
Started: Feb 1, 2012
A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
NCT00241007COMPLETEDPHASE3
836 participants
INTERVENTIONAL
East Hanover, United States
Started: Dec 1, 2003
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
NCT00698646COMPLETEDPHASE4
384 participants
INTERVENTIONAL
Birmingham, United States +19 more
Started: Apr 1, 2008
24 Hour Ambulatory Cardiac Oxygen Consumption
NCT05170061COMPLETEDPHASE3
26 participants
INTERVENTIONAL
Buffalo, United States
Started: Feb 1, 2013
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
NCT00241137COMPLETEDPHASE3
3.79K participants
INTERVENTIONAL
Investigative Centers, Germany
Started: Sep 1, 2003
A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
NCT00171353COMPLETEDPHASE4
109 participants
INTERVENTIONAL
Basel, Switzerland
Started: Jul 1, 2004
Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
NCT00333489COMPLETEDPHASE4
551 participants
INTERVENTIONAL
Basel, Switzerland
Started: Mar 1, 2004
A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension
NCT00171028COMPLETEDPHASE3
90 participants
INTERVENTIONAL
East Hanover, United States
Started: Dec 1, 2003
8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension
NCT00809926COMPLETEDPHASE4
451 participants
INTERVENTIONAL
East Hanover, United States
Started: Jan 1, 2009
A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
NCT00171041COMPLETEDPHASE3
265 participants
INTERVENTIONAL
E.Hanover, United States +1 more
Started: Dec 1, 2002
Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension
NCT00993109COMPLETEDPHASE4
360 participants
INTERVENTIONAL
Guangzhou, China +16 more
Started: Feb 1, 2010
Showing 20 of 262 total trials